← Back to Search
Peroxisome Proliferator‐activated Receptor (PPAR) Agonists Decrease Lipoprotein Lipase Secretion And Glycated LDL Uptake By Human Macrophages
F. Gbaguidi, G. Chinetti, D. Milosavljevic, E. Teissier, J. Chapman, G. Olivecrona, J. C. Fruchart, S. Griglio, J. Fruchart-Najib, B. Staels
Published 2002 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Lipoprotein lipase (LPL) acts independently of its function as triglyceride hydrolase by stimulating macrophage binding and uptake of native, oxidized and glycated LDL. Peroxisome proliferator‐activated receptors (PPARs) are nuclear receptors expressed in monocyte/macrophages, where they control cholesterol homeostasis. Here we study the role of PPARs in the regulation of LPL expression and activity in human monocytes and macrophages. Incubation of human monocytes or macrophages with PPARα or PPARγ ligands increases LPL mRNA and intracellular protein levels. By contrast, PPAR activators decrease secreted LPL mass and enzyme activity in differentiated macrophages. These actions of PPAR activators are associated with a reduced uptake of glycated LDL and could influence atherosclerosis development associated with diabetes.
This paper references
Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages*
G. Chinetti (1998)
Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
A. Li (2000)
Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages.
R. Zimmermann (2001)
Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification.
D. Myers (1996)
Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching.
J. Frank (1989)
Expression and Regulation of the Lipoprotein Lipase Gene in Human Adrenal Cortex*
B. Staels (1996)
Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.
J. Zhang (1998)
Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine.
D. Stengel (1998)
B G Nordestgaard (1995)
Enhancement of the Binding of Triglyceride-rich Lipoproteins to the Very Low Density Lipoprotein Receptor by Apolipoprotein E and Lipoprotein Lipase (*)
S. Takahashi (1995)
Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides.
P. Belfrage (1969)
Atherogenesis: a postprandial phenomenon.
D. B. Zilversmit (1979)
Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions.
J. Luoma (1994)
Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.
W. L. Hendriks (1997)
CD36 is a receptor for oxidized low density lipoprotein.
G. Endemann (1993)
Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions.
A. Ravandi (2000)
Lipoprotein lipase can function as a monocyte adhesion protein.
J. Obunike (1997)
Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media.
B. G. Nordestgaard (1995)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G. Chinetti (2000)
Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
T. Seo (1997)
Peroxisome proliferator-activated receptor-α ligands inhibit cardiac lipoprotein lipase activity
R. Carroll (2001)
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
J. Rapp (1994)
Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs.
S. E. Michaud (2001)
Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates
Anne-Marie Lefebvre (1997)
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.
G. Chinetti (2000)
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.
O. Braissant (1996)
Thiazolidinediones Inhibit Lipoprotein Lipase Activity in Adipocytes*
S. Ranganathan (1998)
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.
M. Ricote (1998)
Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins.
B. Chung (1994)
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
J. Jiang (1998)
Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.
S. K. Basu (1976)
Oxidized LDL binding to a macrophage-secreted extracellular matrix.
M. Kaplan (1997)
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.
S. Gianturco (1982)
A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein.
L. Stanton (1992)
The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).
B. Staels (1997)
Glycated low‐density lipoprotein and atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia?
W. Graier (1997)
Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro
N. Marx (1998)
PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.
K. Schoonjans (1996)
Localization of lipoprotein lipase mRNA in selected rat tissues.
I. Goldberg (1989)
Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.
M. Brown (1983)
Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR7 and RXRa
P. Tontonoz (1994)
Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL.
S. Whitman (1998)
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
P. Tontonoz (1998)
Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages.
W. L. Hendriks (1996)
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
P. Tontonoz (1994)
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
G. Chinetti (2001)
The arterial wall and the atherosclerotic lesion
J. Guyton (1994)
Triglyceride lpases and atherosclerosis
G. Olivecrona (1995)
Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro. Effect of triglyceride-rich lipoproteins.
O. Sofer (1992)
Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products.
J. Rutledge (1997)
This paper is referenced by
Master Author Index
T. Jarchau (2005)
Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis
Alexandra Stanley (2019)
Sorting out the roles of PPARα in energy metabolism and vascular homeostasis
P. Lefebvre (2006)
Peroxisome Proliferator-Activated Receptors and Atherogenesis: Regulators of Gene Expression in Vascular Cells Nuclear Receptor Signaling in the Control of Cholesterol Homeostasis Nuclear Receptor Signaling and Cardiac Energetics
Nikolaus Marx (2004)
Exploring the activation and function of PPARα and PPARβ/δ using genomics.
L. Sanderson (2009)
Papel del receptor alpha actitivado por proliferadores de peroxisoma en la fisiopatología del sistema cardiovascular
José Illnait-Ferrer (2014)
Endothelial progenitor cells regenerate infracted myocardium with neovascu-larisation development
M. A. Aziz (2013)
Pleiotropic effects of fibrates
G. Chinetti-Gbaguidi (2005)
ATVB In Focus Lipoproteins, Inflammation, and Atherosclerosis
Mercedes Ricote (2004)
Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1.
Laeticia Lichtenstein (2010)
Macrophage differentiation to foam cells.
P. Shashkin (2005)
Nuclear receptor signaling in macrophages.
A. Valledor (2004)
Abietic acid activates peroxisome proliferator‐activated receptor‐γ (PPARγ) in RAW264.7 macrophages and 3T3‐L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism
N. Takahashi (2003)
Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.
G. Chinetti (2006)
Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia
E. Nikitin (2007)
Estrogen induces endothelial progenitor cells proliferation and migration by estrogen receptors and PI3K-dependent pathways.
X. Zhao (2008)
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
S. Kersten (2008)
PPARs and the cardiovascular system.
Milton Hamblin (2009)
Physical and functional interactions between nuclear receptor LXRα and the forkhead box transcription factor FOXA2 regulate the response of the human lipoprotein lipase gene to oxysterols in hepatic cells.
M. Kanaki (2017)
Peroxisome proliferator‐activated receptors – from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease
M. A. Bouhlel (2008)
PPARα in atherosclerosis and inflammation
F. Zandbergen (2007)
Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
M. Ricote (2004)
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
M. Rakhshandehroo (2010)
Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function
G. Chinetti (2003)
Vascular lipases, inflammation and atherosclerosis.
S. Hasham (2006)
Di-n-butyl phthalate modifies PMA-induced macrophage differentiation of THP-1 monocytes via PPARγ.
Vegard Sæter Grytting (2019)
The effects of running exercise on oxidative capacity and PGC-1α mRNA levels in the soleus muscle of rats with metabolic syndrome
F. Nagatomo (2011)
Peroxisome Proliferator-Activated Receptor-γ Agonists for Management and Prevention of Vascular Disease in Patients with and without Diabetes Mellitus
Ramón Rios-Vázquez (2006)
Peroxisome proliferator-activated receptor α and γ agonists upregulate human macrophage lipoprotein lipase expression
L. Li (2002)
Perinatal phthalate and high-fat diet exposure induce sex-specific changes in adipocyte size and DNA methylation.
Laura Moody (2019)
Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients.
F. Forcheron (2002)
Atherosclerosis and cardiovascular risk reduction with PPAR agonists
J. Kuusisto (2007)See more